G protein-coupled receptor modulator - Taisho Pharmaceutical

Drug Profile

G protein-coupled receptor modulator - Taisho Pharmaceutical

Latest Information Update: 21 Mar 2014

Price : $50

At a glance

  • Originator Arena Pharmaceuticals; Taisho Pharmaceutical
  • Developer Taisho Pharmaceutical
  • Class
  • Mechanism of Action G protein-coupled receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Psychiatric disorders

Most Recent Events

  • 01 Jan 2013 Discontinued - Phase-I for Psychiatric disorders in Japan (PO)
  • 07 May 2008 Phase-I clinical trials in Psychiatric disorders in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top